Home
About
Overview
Sharing Data
ORCID
Help
History (47)
Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Fingolimod Hydrochloride
Life Cycle Stages
Philadelphia Chromosome
Considerations in the Sickle Cell Patient Undergoing Hip Reconstructive Surgery.
See All 47 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Considerations in the Sickle Cell Patient Undergoing Hip Reconstructive Surgery.
Considerations in the Sickle Cell Patient Undergoing Hip Reconstructive Surgery. Orthop Clin North Am. 2022 Oct; 53(4):421-430.
View in:
PubMed
subject areas
Anemia, Sickle Cell
Arthroplasty, Replacement, Hip
Humans
Osteonecrosis
Pain
Quality of Life
authors with profiles
Sara J Sustich